pSivida makes board appointments
This article was originally published in Scrip
Executive Summary
The US drug delivery company pSivida has appointed Peter Savas and Paul Hopper as non-executive directors. Mr Savas is chairman and chief executive officer of Alseres Pharmaceuticals, a company developing biopharmaceutical products for the diagnosis of degenerative neurological diseases and the treatment of acute spinal cord injury, while Mr Hopper is the founder and lead director of Polynoma and also a director of Somnomed, which manufactures and markets a dental device for sleep disorders.